Correction to "Discovery, Characterization, and Structure-Based Optimization of Small-Molecule In Vitro and In Vivo Probes for Human DNA Polymerase Theta".

Autor: Stockley ML, Benedetti G, Blencowe P, Boulton SJ, Boyd SM, Calder M, Charles MD, Edwardes LV, Ekwuru T, Ferdinand A, Finch H, Galbiati A, Geo L, Grande D, Grinkevich V, Higgins GS, Holliday ND, Krajewski WW, MacDonald E, Majithiya JB, McCarron H, McWhirter CL, Patel V, Pedder C, Rajendra E, Ranzani M, Rigoreau LJM, Robinson HMR, Schaedler T, Sirina J, Smith GCM, Swarbrick ME, Turnbull AP, Willis S, Zemla A, Heald RA

Publikováno v: Journal of medicinal chemistry [J Med Chem] 2023 Feb 23. Date of Electronic Publication: 2023 Feb 23.

Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance.

Autor: Zatreanu D; CRUK Gene Function Laboratory, The Institute of Cancer Research, London, UK.; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Robinson HMR; Artios Pharma, The Glenn Berge Building, Babraham Research Campus, Cambridge, UK., Alkhatib O; Artios Pharma, The Glenn Berge Building, Babraham Research Campus, Cambridge, UK., Boursier M; Artios Pharma, The Glenn Berge Building, Babraham Research Campus, Cambridge, UK., Finch H; Artios Pharma, The Glenn Berge Building, Babraham Research Campus, Cambridge, UK., Geo L; Artios Pharma, The Glenn Berge Building, Babraham Research Campus, Cambridge, UK., Grande D; Artios Pharma, The Glenn Berge Building, Babraham Research Campus, Cambridge, UK., Grinkevich V; Artios Pharma, The Glenn Berge Building, Babraham Research Campus, Cambridge, UK., Heald RA; Artios Pharma, The Glenn Berge Building, Babraham Research Campus, Cambridge, UK., Langdon S; Artios Pharma, The Glenn Berge Building, Babraham Research Campus, Cambridge, UK., Majithiya J; Artios Pharma, The Glenn Berge Building, Babraham Research Campus, Cambridge, UK., McWhirter C; Artios Pharma, The Glenn Berge Building, Babraham Research Campus, Cambridge, UK., Martin NMB; Artios Pharma, The Glenn Berge Building, Babraham Research Campus, Cambridge, UK., Moore S; Artios Pharma, The Glenn Berge Building, Babraham Research Campus, Cambridge, UK., Neves J; Artios Pharma, The Glenn Berge Building, Babraham Research Campus, Cambridge, UK., Rajendra E; Artios Pharma, The Glenn Berge Building, Babraham Research Campus, Cambridge, UK., Ranzani M; Artios Pharma, The Glenn Berge Building, Babraham Research Campus, Cambridge, UK., Schaedler T; Artios Pharma, The Glenn Berge Building, Babraham Research Campus, Cambridge, UK., Stockley M; Artios Pharma, The Glenn Berge Building, Babraham Research Campus, Cambridge, UK., Wiggins K; Artios Pharma, The Glenn Berge Building, Babraham Research Campus, Cambridge, UK., Brough R; CRUK Gene Function Laboratory, The Institute of Cancer Research, London, UK.; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Sridhar S; CRUK Gene Function Laboratory, The Institute of Cancer Research, London, UK.; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Gulati A; CRUK Gene Function Laboratory, The Institute of Cancer Research, London, UK.; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Shao N; CRUK Gene Function Laboratory, The Institute of Cancer Research, London, UK.; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Badder LM; The Breast Cancer Now Research Unit, King's College London, London, UK., Novo D; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Knight EG; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Marlow R; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.; The Breast Cancer Now Research Unit, King's College London, London, UK., Haider S; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Callen E; Laboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA., Hewitt G; The Francis Crick Institute, London, UK., Schimmel J; Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands., Prevo R; Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, UK., Alli C; Cancer Research UK, Therapeutic Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, UK., Ferdinand A; Cancer Research UK, Therapeutic Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, UK., Bell C; Cancer Research UK, Therapeutic Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, UK., Blencowe P; Cancer Research UK, Therapeutic Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, UK., Bot C; Cancer Research UK, Therapeutic Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, UK., Calder M; Cancer Research UK, Therapeutic Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, UK., Charles M; Cancer Research UK, Therapeutic Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, UK., Curry J; Cancer Research UK, Therapeutic Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, UK., Ekwuru T; Cancer Research UK, Therapeutic Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, UK., Ewings K; Cancer Research UK, Therapeutic Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, UK., Krajewski W; Cancer Research UK, Therapeutic Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, UK., MacDonald E; Cancer Research UK, Therapeutic Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, UK., McCarron H; Cancer Research UK, Therapeutic Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, UK., Pang L; Cancer Research UK, Therapeutic Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, UK., Pedder C; Cancer Research UK, Therapeutic Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, UK., Rigoreau L; Cancer Research UK, Therapeutic Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, UK., Swarbrick M; Cancer Research UK, Therapeutic Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, UK., Wheatley E; Cancer Research UK, Therapeutic Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, UK., Willis S; Cancer Research UK, Therapeutic Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, UK., Wong AC; Cancer Research UK, Therapeutic Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, UK., Nussenzweig A; Laboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA., Tijsterman M; Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands., Tutt A; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.; The Breast Cancer Now Research Unit, King's College London, London, UK., Boulton SJ; Artios Pharma, The Glenn Berge Building, Babraham Research Campus, Cambridge, UK.; The Francis Crick Institute, London, UK., Higgins GS; Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, UK., Pettitt SJ; CRUK Gene Function Laboratory, The Institute of Cancer Research, London, UK. Stephen.Pettitt@icr.ac.uk.; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK. Stephen.Pettitt@icr.ac.uk., Smith GCM; Artios Pharma, The Glenn Berge Building, Babraham Research Campus, Cambridge, UK. Graeme.Smith@artiospharma.com., Lord CJ; CRUK Gene Function Laboratory, The Institute of Cancer Research, London, UK. Chris.Lord@icr.ac.uk.; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK. Chris.Lord@icr.ac.uk.

Publikováno v: Nature communications [Nat Commun] 2021 Jun 17; Vol. 12 (1), pp. 3636. Date of Electronic Publication: 2021 Jun 17.

Diets containing phytobiotics, l‐arginine, vitamin E and captopril modulate ascites syndrome‐related genes expression in broiler chickens exposed to low ambient temperature.

Autor: Shirzadi, Hassan¹ (AUTHOR) h.shirzadi@ilam.ac.ir, Shariatmadari, Farid² (AUTHOR), Karimi‐Torshizi, Mohammad Amir² (AUTHOR), Masoudi, Ali Akbar³ (AUTHOR), Rahimi, Shaban² (AUTHOR), Saba, Fakhredin⁴ (AUTHOR), Zaboli, Gholamreza⁵ (AUTHOR), Hedayat‐Evrigh, Nemat⁶ (AUTHOR)

Publikováno v: Veterinary Medicine & Science. Sep2024, Vol. 10 Issue 5, p1-11. 11p.

Six-Month Effectiveness of Remote Activity Monitoring for Persons Living With Dementia and Their Family Caregivers: An Experimental Mixed Methods Study.

Autor: Gaugler JE; Division of Health Policy & Management, School of Public Health., Zmora R; Division of Epidemiology & Community Health, School of Public Health., Mitchell LL; Department of Psychology, College of Liberal Arts., Finlay JM; Department of Geography, Environment, and Society, College of Liberal Arts, Center on Aging., Peterson CM; Division of Epidemiology & Community Health, School of Public Health., McCarron H; School of Public Health, University of Minnesota, Minneapolis., Jutkowitz E; Department of Health Services, Policy & Practice, Brown University School of Public Health, Providence, Rhode Island.

Publikováno v: The Gerontologist [Gerontologist] 2019 Jan 09; Vol. 59 (1), pp. 78-89.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.